Rathi V. Iyer
PROFESSOR EMERITUS
Education
| Children's Hospital of Michigan, Detroit, MI, MBBS, Fellowship in pediatric hematology/oncology | 1970 |
| Detroit General Hospital and Sinai Hospital, Detroit, MBBS, Pediatric Residency | 1968 |
| Worcester City Hospital, Worcester, Massachusetts, MBBS, Internship | 1967 |
| Gandhi Hospital, MBBS, House Surgeon | 1966 |
| Gandhi Medical College of Osmania University, MBBS, Medicine | 1966 |
Specialty Certification Licensure
| UPIN, UPIN | |
| Certification, American Bord of Pediatrics; Hem/Onc Subboard | 1976 - Present |
| Certification, American Board of Pediatrics | 1975 - Present |
| DEA, (DEA) Controlled Substance Registration Certificate | 10/2009 - 11/2012 |
| Certification, PALS Provider, American Heart Association | 04/2010 - 04/2012 |
| Licensure, Sate of Mississippi Medical License, Mississippi State Boad of Medical Licensure | 07/1973 - 06/2011 |
Current Positions
| Director of Hematology Services, School of Medicine, Department of Pediatrics | 07/2007 - Present |
| Professor, School of Medicine, Department of Pediatrics | 07/1993 - Present |
| The University of Mississippi Medical Center Jackson, Mississippi 39216 | |
Academic Appointments or Other Previous Appointments
| Associate Professor, University of Mississippi Medical Center, School of Medicine, Department of Pediatrics | 07/1986 - 06/1993 |
| Assistant Professor, University of Mississippi Medical Center, School of Medicine, Department of Pediatrics | 07/1973 - 06/1986 |
Sponsored Program Funding
| Extramural, Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting Disorders, CDC/The American Thrombosis and Hemostasis Network (ATHN)/HOG | 09/2012 - 09/2014 |
| Extramural, TCD with Transfusions Changing to Hydroxyurea (TWiTCH), NIH/Baylor | 08/2012 - 07/2013 |
| Extramural, MSDH Pediatric Sickle Cell/Hemoglobinopathy Program, Mississippi State Department of Health | 07/2012 - 06/2013 |
| Extramural, MSDH Sickle Cell Case Management and Referral Services, Mississippi State Department of Health | 07/2012 - 06/2013 |
| Extramural, Comprehensive Care in Hemophilia Patients, Department of Health, Education and Welfare Maternal Child Health | 06/2012 - 05/2013 |
| Extramural, Prevention of Stroke after Stop, A Retrospective Chart Review (Post-Stop), Medical University of South Carolina | 06/2012 - 05/2013 |
| Extramural, Blood Safety Surveillance Among Persons with Sickle Cell Disease in Mississippi, CDC | 05/2012 - 04/2014 |
| Extramural, BABY HUG Follow-Up Study - II Clinical Sites, National Heart, Lung and Blood Institute | 01/2012 - 12/2016 |
| Extramural, A Phase III Prospective, Randomized, Double-blind Placebo-controlled, Paralle-group, Multicenter Study of L-Glutamine Therapy for sickle Cell Anemia and Sickle B-Thalassemea, Emmaus Medical Inc | 11/2011 - 12/2012 |
| Extramural, MSDH Pediatric Sickle Cell/Hemoglobinopathy Program, Mississippi State Department of Health | 07/2011 - 06/2012 |
| Extramural, MSDH Sickle Cell Case Management and Referral Services, Mississippi State Department of Health | 07/2011 - 06/2012 |
| Extramural, Comprehensive Care in Hemophilia Patients, Department of Health, Education and Welfare Maternal Child Health | 06/2011 - 05/2012 |
| Extramural, Patent Foramen Ovale and Strokein Sickle Cell Disease (PFAST), Doris Duke Foundation/University of Texas Southwestern Medical Center | 03/2011 - 04/2013 |
| Extramural, Children's Oncology Group Chairs Grant, National Childhood Cancer Foundation | 03/2011 - 02/2012 |
| Extramural, ATHNdataquality.counts, American Thrombosis & Hemostatsis Network | 01/2011 - 01/2013 |
| Extramural, Region IV South Program for the Prevention of the Complications of Hemophilia Through Hemophilia Treatment Centers, Centers for Disease Control and Prevention | 10/2010 - 09/2011 |
| Extramural, Hemoglobinopathy surveillance Data and Education Services, Mississippi State Department of Health | 09/2010 - 07/2011 |
| Extramural, MSDH Pediatric Sickle Cell/Hemoglobinopathy Program, Mississippi State Department of Health | 07/2010 - 06/2011 |
| Extramural, MSDH/CMP Sickle Cell Care Coordination Service Program, Mississippi State Department of Health | 07/2010 - 06/2011 |
| Extramural, A 5-year Prospective, Non-interventional Multicenter Registry in Sickle Cell Disease, Novartis Pharmaceuticals | 01/2010 - 12/2017 |
| Extramural, A Phase 2 Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Pharmacokinetics of GMI-1070, a Pan-Selectin Inhibitor, In Subjects Hospitalized For Sickle Cell Vaso-occlusive Crisis | 12/2009 - Present |
| Extramural, The Mechanisms of Race-Based Differences in Factor Viii Immunogenicity in Hemophilia, NIh/NHLBI/Sepulveda Research Corporation | 09/2009 - 08/2011 |
| Extramural, Investigation of Gene Variants Associated with Resistance and Susceptibility to HIV-1 Exposed but Uninfected Individuals with Hemophilia A (CHAVI 014), NIH | 07/2009 - 06/2010 |
| Extramural, Hemophilia Inhibitor Genetics Study (HIGS), Baxter Bio-Science/RHO Inc | 05/2009 - 09/2011 |
| Extramural, Additional Centers for the Sickle Cell Disease Clinical Research Network Study #1: PROACTIVE Feasibility; Study #2 Improve, NIH /New England Research Institute | 01/2009 - 03/2011 |
| Extramural, Stroke with Transfusions Changing to Hydorxyurea (SWiTCH), National Institute of Health | 08/2008 - 07/2010 |
| Extramural, Iron Loading in Children with Sickle Cell Disease on Chronic Transfusion for Primary Stroke Prevention (STOP/STOPII liver iron ancillary study). Protocol No. CICL670AUS06., Morehouse School of Medicine | 01/2006 - 12/2006 |
| Extramural, The HTRS Registry, Hemophilia and Thrombosis Research Society | 12/2004 - 09/2012 |
| Extramural, Silent Cerebral Infarct Multi-Center Clinical Trial (SIT), National Institute of Health | 09/2003 - 12/2012 |
| Extramural, Second Multicenter Hemophilia Cohort Study( MHCS-II ) Study of hepatitis C and complications in hemophilia patients, The Viral Epidemiology Branch of NCI | 01/2001 - 12/2005 |
| Extramural, Pediatric Hydroxyurea Phase III Clinical Trial and Follow-up, National Heart, Lung and Blood Institute | 09/2000 - 06/2012 |
| Extramural, Optimizing Primary Stroke Prevention in Children with Sickle Cell Anemia (STOP II), NIH/Medical College of Georgia | 08/2000 - 07/2005 |
| Extramural, Intron A+ Ribavirin for Treatment of Patients with Inherited Coagulation Disorders and Chronic Hepatitis C, Schering Plough Corporation | 01/1999 - 12/2001 |
| Extramural, Multicenter Study of Hip Coring Decompression of AVN in Sickle Cell Disease | 01/1998 - 12/2003 |
| Extramural, Ryan White Care Act III - Outpatient Early Intervention Services with Respect to HIV Diseases, HRSA | 01/1991 - 12/1998 |
Publications
Journal Article | |
| Thornburg C, Files B, Lue Z, Miller S, Kalpatthi R, Iyer R, Seaman P, Lebensburger J, Alvarez O, Thompson B, Ware R, Wang W: Impact of Hydroxyurea on clinical events in the BABY HUG trial Blood August 22, 2012 blood-2012-03-419879. Impact of Hydroxyurea on clinical events in the BABY HUG trial Blood. August 22, 2012; blood-2012-03-419879. | 2012 |
| Ware RE, Helms RW, for the SWiTCH Investigators Stroke with Transfusions Changing to Hydroxyurea (SWiTCH) Blood. 2012;119:3925-3932 | 2012 |
| Majumdar S, Ahmad N, Karlson C, Morris A, Iyer R Does weight reduction in haemophilia lead to a decrease in joint bleeds? Haemophilia. May 2012; Volume 18: issue 3, e82-e84 | 2012 |
| DeBaun MR, Sarnaik SA, Rodeghier MJ, Minniti CP, Howard TH, Iyer RV, Inusa B, Telfer PT, Kirby-Allen M, Quinn CT, Bernaudin F, Airewele G, Woods GM, Panepinto JA, Fuh B, Kwiatkowski JK, King AA, Rhodes MM, Thompson AA, Heiny ME, Redding-Lallinger RC, Kirkham FJ, Sabio H, Gonzalez CE, Saccente SL, Kalinyak KA, Strouse JJ, Fixler JM, Gordon MO, Miller JP, Michael J. Noetzel MJ, Ichord RN, and Casella JF. Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure. Blood 2012 119:3684-3690; published ahead of print November 17, 2011, doi:10.1182/blood-2011-05-349621 | 2012 |
| Styles L, Wager CG, Labotka RJ, Smith-Whitley K, Thompson AA, Lane PA, McMahon LE, Miller R, Roseff SD, Iyer RV, Hsu LL, Castro OL, Ataga KI, Onyekwere O, Okam M, Bellevue R, Miller ST; for the Sickle Cell Disease Clinical Research Network (SCDCRN). Refining the value of secretory phospholipase A(2) as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE). Br J Haematol. 2012, 157, 627-636 | 2012 |
| Ware RE, Schultz WH, Yovetich N, Mortier NA, Alvarez O, Hilliard L, Iyer RV, Miller ST, Rogers ZR, Scott JP, Waclawiw M, Helms RW Stroke with transfusions changing to hydroxyurea (SWiTCH): A phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload. Pediatric Blood Cancer. 2011 Dec 1;57(6):1011-1017. doi: 10.1002/pbc.23145 | 2011 |
| Lebensburger JD, Miller St, Howar TH, Casella JF, Brown RC, Lu M, Iyer RV, Sarnaik s, Rogers ZR, Wang WC Influence of severity of anemia on clinical findings in infants with sickle cell anemia: Analyses from the BABY HUG study. Pediatric Blood Cancer. 2011; 59:675-678 | 2011 |
| Wang W, Ware R, Miller S, Iyer R, Casella J, Minniti C, Rana S, Thornburg C, Rogers Z, Kalpatthi R, Barredo J, Brown RC, Sarnaik S, Howard T, Wynn L, Kutlar A, Armstrong D, Files B, Goldsmith J, Waclawiw M, Huange X, Thompson B, for the BABY HUG investigators Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG) The Lancet. 2011; 377, 9778, 1663 - 1672 doi:10.1016/S0140-6736(11)60355-3 Cite or Link Using DOI http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)60355-3/fulltext | 2011 |
| Rogers ZR, Wang WC, Luo Z, Iyer RV, Shalaby-Rana E, Dertinger SD, Shulkin BL, Miller JH, Files B, Lane PA, Thompson BW, Miller ST, Ware RE, and for the BABY HUG Investigators Biomarkers of splenic function in infants with sickle cell anemia: baseline data from the BABY HUG Trial BLOOD, 3 March 2011, Vol. 117, No. 9, pp. 2614-2617. Prepublished online as a Blood First Edition Paper on January 7, 2011; DOI 10.1182/blood-2010-04-278747. | 2011 |
| Majumdar S, Ostrenga A, Latzman R , Payen C, Hunt Q, Morris A, Iyer R Pharmacoeconomic impact of obesity in hemophilia in children with severe hemophilia in a single institution Haemophilia, 2010 IN PRESS Article first published online: 16 FEB 2011 DOI: 10.1111/j.1365-2516.2010.02462.x | 2011 |
| Latzman R, Majumdar S, Bigelow C, Elkin D, Smith M, Megason G, Srivastava P, and Iyer R Transitioning to adult care among adolescents with sickle cell disease: A transitioning clinic based on patient and caregiver concerns and needs International Journal of Child and Adolescent Health, Special Edition, 2010;3(4):00-00. | 2010 |
| Majumdar S, Morris, A, Gordon C, Kermode JC, Forsythe A, Herrington B, Megason, GC, Iyer RV Alarmingly high prevalence of obesity in haemophilia in the state of Mississippi Haemophilia Vol 16: 3: pp 455-459, May 2010 DOI: 10.1111/j.1365-2516.2009.02187.x | 2010 |
| Majumdar S, Robertson Z, Robinson A, Starnes S, Iyer R, Megason GC: Outcome of hematopoietic cell transplantation in children with sickle cell disease, a single center’s experience. Bone Marrow Transplant. 2010; 45(5): 895-900 | 2010 |
| Thompson B, Miller S, Rogers Z, Rees R, Ware R, Waclawiw M, Iyer R, Casella J, Luchtman-Jones L, Rana S, Thornburg C, Kalpatthi R, Barredo J, Brown R, Sarnaik S, Howard T, Luck L, Wang W The pediatric hydroxyurea phase III clinical trial (BABY HUG): Challenges of study design Pediatric Blood and Cancer 54:250-255, February 2010 DOI: 10.1002/pbc.22269 | 2010 |
| Pavlakis S, Rees R, Huang X, Brown R, Casella J, Iyer R, Kalpatthi R, Luden J, Miller S, Rogers Z, Thornburg C, Wang W, Adams R, for the BABY HUG Investigators Transcranial doppler ultrasonography (TCD) in infants with sickle cell anemia: Baseline data from the BABY HUG Trial Pediatric Blood & Cancer 54:256-259, February 2010 DOI: 10.1002/pbc.22282 | 2010 |
| Miller ST, Wang WC, Iyer R, Rana S, Lane P, Ware RE, Li D, Rees RC, Clinical Trials & Surveys Corporation, for the BABY UG investigators Urine concentrating ability in infants with sickle cell disease: Baseline data from the phase III trial of Hydroxyurea (BABY HUG) Pediatric Blood and Cancer 54:265-268 | 2010 |
| The BABY HUG Investigators, Ware R, Rees R, Sarnaik S, Iyer R, Alvarez O, Casella J, Shulkin B, Shalaby-Rana E, Strife C, Miller J, Lane P, Wang W, Miller S, Renal function in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial The Journal of Pediatrics 156:66-70, January 2010 doi:10.1016/j.jpeds.2009.06.060 | 2010 |
| Adamkiewicz T, Abboud M, Paley C, Olivieri N, Kirby-Allen M, Vichinsky E, Casella J, Alvarez O, Barredo J, Lee M, Iyer R, Kutlar A, McKie K, McKie V, Odo N, Gee B, Kwiatkowski J, Woods G, Coates T, Wang W, Adams R Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are non-linear, and are associated with iron load and liver injury Blood, 19 November 2009, Vol. 114, No. 21, pp. 4632-4638. DOI 10.1182/blood-2009-02-203323. | 2009 |
| Majumdar S, Robertson Z, Robinson A, Starnes S, Iyer R, Megason G Outcome of hematopoietic cell transplantation in children with sickle cell disease, a single center’s experience: Bone Marrow Transplantation. 2009.244 doi:10.1038/bmt.2009.244 | 2009 |
| Viel KR, Ameri A, Abshire T, Iyer R, Watts R, Lutcher C, Channell C, Cole S, Fernstrom K, Nakaya S, Kasper C, Thompson A, Almasy A, Howard T Inhibitors of Factor VIII in Black Patients with Hemophilia New England Journal of Medicine 2009; 360:1618-27 | 2009 |
| Thornburg CD, Rogers ZB, Wang W, Jeng M, Rana SR, Iyer RV, Faughman L, Marshall J, Hassen L, McDonald R, Rees RC Study Drug and Visit Adherence: Data from the BABY HUG Trial Blood. 2008; 112: 1275 | 2008 |
| Jordan S, Hilker K, Stoppelbein L, Elkin D, Applegate H, Iyer R Nocturnal Enuresis and Psychosocial Problems in Pediatric Sickle Cell Disease and Sibling Controls Journal of Developmental and Behavioral Pediatrics Vol.26, No.6, December 2005 | 2005 |
| Adamkiewicz T, Sarnaik S, Buchanan G, Iyer R, Miller S, Pegelow C, Rogers Z, Vichinsky E, Elliott J, Facklam R, O'Brien K, Schwartz B, Cannon M, Eckman J, Keyserling H, Sullivan K, Wong W, Wang W Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination Journal of Pediatrics, Volume 143: 438-444, October 2003 | 2003 |
| Dean D; Neumayr L; Kelly DM; Ballas SK; Kleman K; Robertson S; Iyer RV; Ware RE; Koshy M; Rackoff WR; Pegelow CH; Waldron P; Benjamin L; Vichinsky E Acute Chest Syndrome Study Group: Chlamydia pneumoniae and acute chest syndrome in patients with sickle cell disease Journal of Pediatric Hematology/Oncology 01-Jan-2003;25(1):46-55 | 2003 |
| Malouf A, Hamrick-Turner J, Doherty M, Dhillon G, Iyer R, Smith MG Implementation of the STOP protocol for stroke prevention in sickle cell anemia utilizing duplex power doppler: a prospective study Radiology, 2001, 219: 359 - 365 | 2001 |
| Iyer R, Baliga R, Nagel RL, Brugnara C, Kirchner K, Hogan S, Steinberg MH Maximum urine concentrating ability and hematological indices in children with Hb SC disease: Effects of Hydroxyurea American Journal of Hematology, 2000 64:47-52 DOI: 10.1002/(SICI)1096-8652(200005) | 2000 |
| Neul S, Elkin TD, Applegate H, Griffin K, Bockewitz L, Iyer R, Smith MG, Mitchell T Developmental Concepts of Disease and Pain in Pediatric Sickle Cell Patients Children’s Health Care, 2003, 32(2), 81-101 | |
| Applegate H, Webb P, \Elkin TD, Neul S, Drabman R, Moll G, Jr, Pullen J, Smith MG, Iyer R, Megason G Improving Parent Participation at Pediatric Diabetes and Sickle Cell Appointments Using a Brief Intervention Children’s Health Care, 2003, 32(2), 125-136. DOI: 10.1207/S15326888CHC3202_4 | |
Abstracts | |
| Rogers Z, Rees R, Files B, Iyer RV, Shulkin B, halaby-Rana E, Miller J, Dertinger S, Lane P, Wang W, Ware R and the BABY HUG Investigators Spleen Function in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG trial. Annual SCD Scientific Meeting, Ft. Lauderdale, FL | 2009 |
| Wang WC, Rees RC, Miller ST, Brown RC, Casella JF, Iyer R, Kalpatthi R, Luden J, Rogers ZR, Thornburg C, Adams RJ, Pavlakis S for the BABY HUG Investigators Transcranial Doppler (TCD) ultrasonography in infants with sickle cell anemia: baseline data from the BABY HUG Trial 50th Annual Meeting, ASH, San Francisco CA, December 2008. Blood 2008:112:1436. | 2008 |
| Ware RE, Rees RC, Sarnaik SA, Iyer RV, Alvarez OA, Casella JF, Shulkin BL, Shalaby-Rana E, Strife CF, Miller JH, Lane PA, Wang WC, Miller ST, and The BABY HUG Investigators Renal Function in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial Blood. 2008; 112: 1414 | 2008 |
| Miller S, Ware R, Kutlar A, Alvarez O, Iyer R, Sarnaik S, Rana S, Rogers Z, Lane P,Rees R, The BABY HUG Investigators Serum Cystatin-C Levels in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial Blood (ASH Annual Meeting Abstracts), Nov 2008; 112: 4791. | 2008 |
| Rogers ZR, Rees RC, Files B, Iyer RV, Shulkin BL, Shalaby-Rana E, Miller JH, Dertinger SD, Lane PA, Wang WC, Ware RE, The BABY HUG Investigators Spleen Function in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial Blood. 2008; 112: 1416 | 2008 |
| Thornburg CD, MD, Rogers ZB, Wang w, Jeng M, Rana SR, Iyer RV, Faughman L, Marshall J, Hassen L, McDonald R, Rees RC Study Drug and Visit Adherence: Data from the BABY HUG Trial Blood (ASH Annual Meeting Abstracts), Nov 2008; 112: 1275. | 2008 |
| Miller ST, Wang WC, Iyer RV, Rana SR, Lane PA, Jr., Ware RE, Rees RC, The BABY HUG Investigators Sickle Cell Anemia: Baseline Data from the BABY HUG Trial Urine Concentrating Ability in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial. Blood. 2008; 112:1413 | 2008 |
| Majumdar S, Smith mg, Megason gc, Iyer RV, Kermode JC In vitro platelet activation in sickle cell disease under pathophysiological shear stress Presented 21st Annual ASPHO Meeting Abstracts, May 2008. Abstract 1275. Poster 143. | 2008 |
| Majumdar S, Robertson Z, Robinson A, Starnes S, Iyer R, Megason G Outcome of Hematopoietic Cell Transplantation in Children with Sickle Cell Disease, a Single Center’s Experience Blood. 2007; 110: 1112 | 2007 |
| Ware RE, McMurray MA, Schultz WH, Alvarez OA, Aygun B, Academic Community Standards for Chronic Transfusion Therapy in Children with Sickle Cell Anemia and Stroke Blood. 2006; 108:1213 | 2006 |
| Howard TE, Viel KR, Fernstrom KM, Deshpande S, Afshin am, Showkat A, Channell C, Iyer RV, Watts RG, Lutcher C, Nakaya S, Kasper CK, Thompson AR, Abshire TC, Almasy L Allelically Mismatched Replacement Therapy Due to Common African-Restricted Haplotypes of the Factor (F)VIII Protein May Underlie the Increased Incidence of FVIII Inhibitors Observed in Hemophilia-A Patients of African-Descent Simultaneous Session: Coagulation and Hemophilia: Oral Session: Presented at 48th Annual Meeting December, 2006. Blood (ASH Annual Meeting Abstracts), Nov 2006; 108: 765. | 2006 |
| Adamkiewicz T, Abboud MR, Barredo JC, Kirby-Allen M, Alvarez OA, Serum Ferritin in Children with Sickle Cell Disease on Chronic Transfusion: Measure of Iron Overload or End Organ Injury? STOP/STOP II Liver Iron Ancillary Study Blood, 2006; 108: 791 | 2006 |
| Adamkiewicz T, Abboud MR, Barredo JC, Kirby-Allen M, Alvarez OA, Casella JF, Iyer RV, McKie V, Woods GM, Kutlar A, Paley C, Peterson J, Rackoff E, Merelles-Pulcini , Dackiw E, Stegenga K, Odo N, Lou M, Adams R Serum Ferritin in Children with Sickle Cell Disease on Chronic Transfusion: Measure of Iron Overload or End Organ Injury? STOP/STOP II Liver Iron Ancillary Study Oral Session: Simultaneous Session: Hemolysis, Transfusion, and End Organ Dysfunction in Sickle Cell Disease: Presented at 48th Annual Meeting December, 2006. Blood (ASH Annual Meeting Abstracts), Nov 2006; 108: 791. | 2006 |
| Neumayr L, Morris C, Wen A, Earles A, Robertson S, Abboud M, Ballas S, Browning I, Bellevue R, Daeschner C, Groncy P, Hume HA, Iyer RV, McMahon L, Moncino M, Orringer E, Swerdlow P,Waldron P, Ware R, Vichinsky E National Acute Chest Study Group (NACSG). Presented at the Oral Session: 47th ASH Annual Meeting, December 2005. | 2005 |
| Adams RJ, Barredo J, Bonds DR, Brown C, Casella J, Daner L, Gerber AR, Iyer RV, Luden J, Miller S, Minniti C, Rana S, Rees R, Rogers Z, Toledano S, Wang W, Ware R, Zimmerman S TCD in Infants: A Report from the BABY HUG Trial Presented at the Poster Session: Basic Science and Clinical Practice in Blood Transfusion. 47th ASH Annual Meeting, December, 2005. Blood 2005; 106:280a | 2005 |
| Rogers ZR, Thompson B, Ware RE, Wang WC, Iyer RV, Miller ST, Minniti C, Rana S, Barredo JC Toledano S, Casella JF, Zimmerman SA, Files BA, Waclawiw M, Bonds DR Pharmacokinetics of hydroxyurea in young children with sickle cell anemia: a report from the BABY HUG Trial Blood. 2005;106:890a | 2005 |
| Howard T, Machiah D, Viel K, Channel C, Ameri A, Iyer R, Watts R, Lutcher C, Davis J, Abshire T, Almasy L The Pharmacogenetics and Inhibitor Risk (PIR) Study: Establishing the Spectrum of Factor (F) VIII Gene (F8) in African-American Hemophilia A Patients Blood (ASH Annual Meeting Abstracts) 2005 106: Abstract 3207 | 2005 |
| Ware RE, Miller ST, Rees RC, Iyer RV, Rogers ZR, Zimmerman SA, Minitti C, Barredo J, Rana S, Casella J, Toledano S, Dnner L, Thompson B, Wang WC Assessment of Renal Function in the Phase III Multi Center Hydroxyurea (BABY HUG) Trial For Infants With Sickle Cell Anemia Presented at the annual Sickle Cell Disease Clinical Research Meetings, August 29 – September 2, 2005. | 2005 |
| Rogers ZR, Rees RR, Wang WC, Li D, Iyer RV, Rana S, Barredo JC, Casella JF, Driscoll C, Toledano S, Miller ST, Zimmerman SA, Miller JH, Shalaby-Ranha E, Dertinger S, Thompson B, Ware RE Evaluation of Splenic Function in Infants with Sickle Cell Anemia in the BABY HUG Trial Presented at the annual Sickle Cell Disease Clinical Research Meetings, August 29 – September 2, 2005. | 2005 |
| Rogers ZR, Thompson B, Ware RE, Wang WC, Iyer RV, Miller ST, Minniti C, Rana S, Barredo JC, Toledano S, Zimmerman SA, Casella JF, Files BA, Waclawiw MA, Gerber AR, Bonds DR Pharmacokinetics of Hydroxyurea in Young Children with Sickle Cell Anemia: A Report from the BABY HUG Trial. Presented at the annual Sickle Cell Disease Clinical Research Meetings, August 29 – September 2, 2005. | 2005 |
| Miller S, Barredo J,Brown CR, Bonds DR, Casella JF, Daner L, Rees R, Thompson B, Gerber AR, Iyer RV, Minniti C, Rana S, Rogers ZR, Toledano S, Wang W, Ware R, Zimmerman S Renal Concentrating Ability in Infants With Sickle Cell Anemia; Preliminary Data From BABY HUG, A Multicenter Trial Presented at the annual Sickle Cell Disease Clinical Research Meetings, August 29 – September 2, 2005. | 2005 |
| Ware RE, Miller ST, Rees RC, Iyer RV, Rogers ZR, Zimmerman SA, Minitti C, Barredo J, Rana S, Casella JF, Toledano S, Li D, Thompson B, Wang WC Assessment of Renal Function in the Phase III Multi Center Hydroxyurea (BABY HUG) Trial For Infants With Sickle Cell Anemia Presented at the annual Sickle Cell Disease Clinical Research Meetings | 2005 |
| Rogers ZR, Rees RR, Wang WC, Li D, Iyer RV, Rana S, Barredo JC, Casella JF, Driscoll C, Toledano S, Miller ST, Zimmerman SA, Miller JH, Shalaby-Rana E, Dertinger SD, Thompson B, Ware RE. Evaluation of splenic function in infants with sickle cell anemia in the BABY HUG Trial. Evaluation of splenic function in infants with sickle cell anemia in the BABY HUG Trial. 2005.Blood 2004;104:975a. 28th Annual Meeting of the National Sickle Cell Disease Program, Cincinnati OH, April 2005 | 2005 |
| JF Casella, WC Wang, ZR Rogers, RC Rees, RV Iyer, S Rana, MC Driscoll, ST Miller, S Toledano, Barredo, SA Zimmerman, D Li, RE Ware, B Thompson Progress of the Multicenter Trial of Hydroxyurea in Infants with Sickle Cell Anemia (BABY HUG) and Assessment of Baseline Splenic and Renal Function ASPHO/PAS, Washington DC | 2005 |
| Wang W, Rees R, Li, Rogers Z, Iyer R, Rana S, Barredo J, Casella J, Driscoll C, Toledano S, Miller S, Zimmerman S, Shalaby-Rana,E Miller J, Thompson B, Ware R Evaluation of Renal Function By Glomerular Filtratio Rate (GFR) In Infants With Sickle Cell Anemia Presented 46th ASH Annual Meeting, San Diego, California | 2004 |
| Smith MG, Pullen J, Megason G, Mitchell T, Iyer R Streptococcus pneumoniae endophthalmitis in a patient with homozygous sickle cell disease 24th Annual Meeting of the National Sickle Cell Disease Program, Philadelphia, PA. April 8 - 12, 2000. | 2000 |
| Mitchell TE, Smith MG, Iyer RV, Pullen DJ, Jones BP Zeroderma Pigmentosum presenting as squamous cell carcinoma of the eyelid in a patient with sickle cell disease 24th Annual meeting of the National Sickle Cell Disease Program, Philadelphia, PA. April 8 - 12, 2000. | 2000 |
Presentations
| Poster Presentation, Comparison of Hematologic Measurements Between Local and Central Data from BABY HUG., ASPHO, ASPHO, Baltimore, MD | 04/2011 |
| Platform Presentation, Effects of Hydroxyurea on Cerebral Blood Flow in Sickle Cell Anemia: Results From The BABU HIG Trial, ASPHO, ASPHO Baltimore MD | 04/2011 |
| Poster Presentation, Febrile Episodes and Infections in Young Children with Sickle Cell Anemia (SCA), ASPHO, ASPHO BALTIMORE MD | 04/2011 |
| Poster Presentation, The physiological and clinical effects of interrupting a treatment regimen of hydroxyurea in young children with sickle cell anemia (SCA)., ASH, ASH 2011 accepted as Poster Presentation. | 2011 |
| Poster Presentation, In vitro platelet activation in sickle cell disease under pathophysiological shear stress, ASPHO, 21st Annual ASPHO Meeting | 05/2008 |
| Poster Presentation, Academic Community Standards for Chronic Transfusion Therapy in Children with Sickle Cell Anemia and Stroke. Session Type: Poster Session, Board #341-I, 48th ASH Annual Meeting, Presented at the Poster Session: 48th ASH Annual Meeting December, 2006. Blood (ASH Annual Meeting Abstracts), Nov 2006; 108: 1213. | 11/2006 |
| Poster Presentation, Evaluation of Splenic Function in Infants with Sickle Cell Anemia in the BABY HUG Trial, Presented, 46th ASH Annual Meeting, San Diego, California. December 4 – 7, 2004 (poster) | 12/2004 |
| Poster Presentation, Developmental aspects of pain in children with sickle cell disease., Annual Meeting of the National Sickle Cell Group, New York, NY | 03/2001 |
Honors, Awards, and Recognition
| Gold Award for Excellence in Research at UMMC, University of Mississippi Medical Center | |
| UMC Captains Chair in appreciation of 20 years of service, University of Mississippi Medical Center | |
| Hollaman Award for Outstanding Faculty, Department of Pediatrics, UMMC | |
| letter award - Recognition for Teaching, Dept Chairman, Pediatrics, UMMC |
Professional Membership and Service
| Pediatric Blood and Cancer, Reviewer, Journal Article, Pediatric Blood and Cancer | 2012 - Present |
| Jackson State University, Adjunct Graduate Faculty | 2010 - Present |
| Writing Committee Sickle Cell Disease Clinical Research Network, Member | 2010 - Present |
| Publication Committee Sickle Cell Disease Clinical Research Network, Member | 2009 - Present |
| Writing Committee BABY HUG, Member | 2006 - Present |
| Publication Committee BABY HUG, Member, Publication Committee Conference Calls | 2004 - Present |
Committee Service
| The University Hospitals and Clinics - Blood Transfusion, Member | 2007 - Present |
Community Service
| Links UMMC Sickle Cell Fund, Member | 1999 - Present |
| Camp Sickle Stars, Camp Physician | 1998 - Present |
| MSDH Transition Advisory Committee, Member | 1998 - Present |
| Mississippi Childrens Medical Program, Member | 1997 - Present |
| Mississippi Sickle Cell Foundation, Medical Advisor | 1997 - Present |
| Misissippi Society of Oncology, Member | 1992 - Present |
| Mississippi Chapter, National Hemophilia Foundaton, Advisory Member | 1989 - Present |
| MSDH Newborn Screening for Hemoglobinopathy and Follow-up, Physician Member - Advisory | 1988 - Present |
| Genetic Advisory Comittee MS State Board of Health, Chairman | 1988 - 1991 |
| Camp Rainbow, Camp Physician | 1984 - Present |
| Camp Rainbow for Children with Cancer committee, Member | 1984 - Present |
| Mississippi State Health Adviory Board for Sickle Cell Disease, Member | 1979 - 1981 |
Teaching Experience
| Medicine, Lecture, Lecturer | |
| Medicine, Lecture, Lecturer |
Directed Student Learning
| Dissertation Committee Member, An Investigation of Complimentary Alternative Methods in Conjunction with Pharmacologic Methods of Pain Control For Sickle Cell Disease Patients Advised: Wendy Thompson | 2009 - Present |
Fellows supervised
| Pediatric Hem/Onc Fellowship Program, A Faculty Supervisor, 5 fellows supervised | 07/1990 - Present |
Residency Training
| Pediatric Residency Program, Attending Physician | 1973 - Present |